Since then, further support for a role of altered sphingolipid metabolism has emerged—for example, the most common risk factor for PD is mutations in glucocerebrosidase 1 (GBA1) [52], which is an enzyme involved in hydrolysing the sphingolipid glucocerebroside. This evidence concerns the gene GBA1 and Parkinson disease.